Search Results - "Kong, Shiying"

Impact of pre-existing cardiovascular disease on treatment patterns and survival outcomes in patients with lung cancer by Batra, Atul, Sheka, Dropen, Kong, Shiying, Cheung, Winson Y

“…Baseline cardiovascular disease (CVD) can impact the patterns of treatment and hence the outcomes of patients with lung cancer. This study aimed to…”
Get full text

Eligibility of real-world patients with metastatic breast cancer for clinical trials by Batra, Atul, Kong, Shiying, Cheung, Winson Y.

“…The results of clinical trials in metastatic breast cancer (MBC) are generalized to real-world patients. This study determines the proportion of real-world…”
Get full text

Breast Biopsy During Post-treatment Surveillance of Screen-Detected Breast Cancer Patients Yields High Rates of Benign Findings by Laws, Alison, Xu, Yuan, Kong, Shiying, Brisson, Anne-Marie, Bouchard-Fortier, Antoine, Quan, May Lynn

“…Background The incidence of breast biopsy following treatment for breast cancer is not well-characterized. We sought to determine the frequency and outcomes of…”
Get full text

New method for determining breast cancer recurrence-free survival using routinely collected real-world health data by Jung, Hyunmin, Lu, Mingshan, Quan, May Lynn, Cheung, Winson Y, Kong, Shiying, Lupichuk, Sasha, Feng, Yuanchao, Xu, Yuan

“…In cancer survival analyses using population-based data, researchers face the challenge of ascertaining the timing of recurrence. We previously developed…”
Get full text

Trends in treatment patterns and survival outcomes in advanced non-small cell lung cancer: a Canadian population-based real-world analysis by Carroll, Robert, Bortolini, Margherita, Calleja, Alan, Munro, Robin, Kong, Shiying, Daumont, Melinda J, Penrod, John R, Lakhdari, Khalid, Lacoin, Laure, Cheung, Winson Y

“…As part of the multi-country I-O Optimise research initiative, this population-based study evaluated real-world treatment patterns and overall survival (OS) in…”
Get full text

Factors associated with the initiation of chemotherapy within 90 days of death in metastatic colorectal cancer patients: a population-based study by Batra, Atul, McKinnon, Geoff, Billawala, Alkarim, Sheka, Dropen, Kong, Shiying, Cheung, Winson Y.

“…Introduction Initiation of chemotherapy in patients with cancer near end-of-life (EOL) has become more frequent due to an increasing number of treatment…”
Get full text

Oncocytic subtypes of adrenal cortical carcinoma: Aggressive in appearance yet more indolent in behavior? by Mills, Jane K., Khalil, Moosa, Pasieka, Janice, Kong, Shiying, Xu, Yuan, Harvey, Adrian

“…Adrenal cortical carcinoma is an aggressive malignancy and typically heralds a poor prognosis. The oncocytic subtype of this neoplasm is rare but may be…”
Get full text

Development and validation of case-finding algorithms for recurrence of breast cancer using routinely collected administrative data by Xu, Yuan, Kong, Shiying, Cheung, Winson Y, Bouchard-Fortier, Antoine, Dort, Joseph C, Quan, Hude, Buie, Elizabeth M, McKinnon, Geoff, Quan, May Lynn

“…Recurrence is not explicitly documented in cancer registry data that are widely used for research. Patterns of events after initial treatment such as oncology…”
Get full text

A Population-Based Study to Evaluate the Associations of Nodal Stage, Lymph Node Ratio and Log Odds of Positive Lymph Nodes with Survival in Patients with Small Bowel Adenocarcinoma by Batra, Atul, Kong, Shiying, Hannouf, Malek B, Cheung, Winson Y

“…This study aimed to determine the real-world prognostic significance of lymph node ratio (LNR) and log odds of positive lymph nodes (LOPLN) in patients with…”
Get full text

The influence of adjuvant chemotherapy dose intensity on overall survival in resected colon cancer: a multicentered retrospective analysis by Breadner, Daniel, Loree, Jonathan M, Cheung, Winson Y, Gipson, Meghan, Lakkunarajah, Suganija, Mulder, Karen E, Spartlin, Jennifer L, Kong, Shiying, Ding, Philip Q, Gill, Sharlene, Welch, Stephen A

“…Abstract Background Colorectal cancer remains the second leading cause of cancer death in North America. Fluorouracil and oxaliplatin based adjuvant…”
Get full text

Patient-level factors associated with chronic opioid use in cancer: a population-based cohort study by Cuthbert, Colleen A., Xu, Yuan, Kong, Shiying, Boyne, Devon J., Hemmelgarn, Brenda R., Cheung, Winson Y.

“…Purpose Concerns around chronic opioid use (COU), misuse, and harms have led to increased scrutiny of opioid prescribing in oncology. There is lack of research…”
Get full text

Higher-risk breast cancer in women aged 80 and older: Exploring the effect of treatment on survival by Al-Rashdan, Abdulla, Xu, Yuan, Quan, May Lynn, Cao, Jeffrey Q., Cheung, Winson, Bouchard-Fortier, Antoine, Kong, Shiying, Barbera, Lisa

“…To understand the association between various treatments and survival for older women with higher-risk breast cancer when controlling for patient and tumor…”
Get full text

Acute Care Use by Breast Cancer Patients on Adjuvant Chemotherapy in Alberta: Demonstrating the Importance of Measurement to Improving Quality by Wu, Che Hsuan David, Quan, May Lynn, Kong, Shiying, Xu, Yuan, Cao, Jeffrey Q, Lupichuk, Sasha, Barbera, Lisa

“…Breast cancer patients receiving adjuvant chemotherapy are at increased risk of acute care use. The incidence of emergency department (ED) visits and…”
Get full text

Effectiveness and Safety of First-Line Pembrolizumab in Older Adults with PD-L1 Positive Non-Small Cell Lung Cancer: A Retrospective Cohort Study of the Alberta Immunotherapy Database by Grosjean, Heidi A I, Dolter, Samantha, Meyers, Daniel E, Ding, Philip Q, Stukalin, Igor, Goutam, Siddhartha, Kong, Shiying, Chu, Quincy, Heng, Daniel Y C, Bebb, D Gwyn, Morris, Don G, Cheung, Winson Y, Pabani, Aliyah

“…The emergence of immunotherapy revolutionized the treatment of non-small-cell-lung cancer (NSCLC), with multiple landmark clinical trials establishing the…”
Get full text

Associations Between the Density of Oil and Gas Infrastructure and the Incidence, Stage and Outcomes of Solid Tumours: A Population-Based Geographic Analysis by Jost, Evan, Dingley, Brittany, Jost, Casey, Cheung, Winson Y, Quan, May Lynn, Bouchard-Fortier, Antoine, Kong, Shiying, Xu, Yuan

“…We hypothesized that there are geographic areas of increased cancer incidence in Alberta, and that these are associated with high densities of oil and gas(O+G)…”
Get full text

Real World Outcomes in Patients with Advanced Melanoma Treated in Alberta, Canada: A Time-Era Based Analysis by Rigo, Rodrigo, Doherty, Jordan, Koczka, Kim, Kong, Shiying, Ding, Philip Q., Cheng, Tina, Cheung, Winson Y., Monzon, Jose G.

“…Immune checkpoint and MAP kinase pathway inhibitors can significantly improve long-term survival for patients with melanoma. There is limited real-world data…”
Get full text

Development and validation of case-finding algorithms for recurrence of breast cancer using routinely collected administrative data by Xu, Yuan, Kong, Shiying, Quan, May Lynn

“…IntroductionRecurrence free survival is frequently investigated in cancer outcome studies, however is not explicitly documented in cancer registry data that is…”
Get full text

Understanding real‐world treatment patterns and clinical outcomes in AL amyloidosis patients diagnosed in Canada: A population‐based cohort study by Jimenez‐Zepeda, Victor H., Reece, Donna, Rigo, Rodrigo, Gogna, Priyanka, Kong, Shiying, Hu, Xun Yang, Chapani, Parv, Cheung, Winson Y., Brenner, Darren R., Plante, Richard, Shi, Kun, Husain, Asad, Tankala, Dipti, Boyne, Devon J.

“…Amyloid light chain (AL) amyloidosis is a rare and chronic bone marrow disorder. Existing claims data can be used to help understand the real‐world treatment…”
Get full text

Associations of pre-existing cardiovascular disease (CVD) with treatment patterns and survival outcomes in patients with metastatic prostate cancer: A real-world, population-based study by Batra, Atul, Kong, Shiying, Cheung, Winson Y.

“…Abstract only e17056 Background: Prior cardio-oncology research has focused on examining the future risk of CVD as a result of cancer treatments. The impact of…”
Get full text

Eligibility of real-world patients with stage II/III colorectal cancer (CRC) in adjuvant chemotherapy (AC) trials by Batra, Atul, Kong, Shiying, Cheung, Winson Y.

“…Abstract only 50 Background: The results of AC trials in stage II/III CRC are often generalized to real-world patients. However, clinical trials have stringent…”
Get full text